Pharma Industry News

Evox raises £69.2m to advance exosome-based therapeutics pipeline

Series C financing will also be used for the development of Evox's DeliverEX exosome drug platformOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]